Test Price
3,000 AED✅ Home Collection Available
Dystonia Panel Genetic Test in UAE | NGS Sequencing | 3000 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% clinical sensitivity via ISO 15189 accredited next-generation sequencing workflow.
- Sample Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM.
- Clinical Guidance: Complimentary post-test telephonic interpretation session with a DHA-licensed consultant medical geneticist.
- Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731.
- Turnaround Time: Results delivered within 21–28 business days from sample receipt.
Test Overview & Methodology
The Dystonia Panel Genetic Test employs next-generation sequencing (NGS) to simultaneously analyze 50+ genes associated with primary and hereditary dystonia syndromes. The assay detects single nucleotide variants, small insertions and deletions, and copy number variations across the targeted genomic regions. This focused panel approach delivers a higher diagnostic yield than sequential single-gene testing and provides faster, more interpretable results compared to whole-exome sequencing for dystonia-related indications.
| Feature | Our Dystonia NGS Panel | Alternative (Single-Gene / WES) |
|---|---|---|
| Precision (Diagnostic Yield) | 99.9% sensitivity with deep coverage; clinically validated panel | Variable; single-gene test may miss other dystonia genes; WES often requires longer interpretation |
| Methodology | NGS (Next-Generation Sequencing) with CNV analysis | Sanger sequencing (single gene) or Whole Exome Sequencing (broader but less focused) |
| Turnaround Time | 21–28 business days from sample receipt | 6–12 weeks for WES; 4–6 weeks for single-gene |
Physician Insight & Safety Protocols
A positive genetic finding from this panel indicates a pathogenic or likely pathogenic variant in a dystonia-associated gene, but clinical correlation with a detailed neurological examination is essential for accurate diagnosis. A negative result does not rule out dystonia of non-genetic etiology or variants in genes not covered by the panel. I strongly recommend pre- and post-test genetic counseling for all patients to fully understand the implications for themselves and their at-risk family members. — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
⚠️ Important Medication Notice
Do not discontinue, alter, or adjust any prescribed medications—including anticholinergics, benzodiazepines, muscle relaxants, or botulinum toxin therapy—without direct consultation with your treating physician. Abrupt cessation may precipitate withdrawal symptoms or worsening of dystonic symptoms.
Exclusion Criteria & Safety Red Flags
- Patients unable to provide informed consent or lacking legal guardian consent for minors as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Refusal to complete mandatory pre-test genetic counseling session required for panel testing.
- Inability to provide an adequate blood sample or FTA card due to a documented medical contraindication.
- Emergency Red Flags: If you experience acute dystonic storm, severe muscle rigidity with respiratory distress, or suicidal ideation, seek immediate emergency care. This test is elective and not intended for emergency diagnosis or acute management.
Patient FAQ & Clinical Guidance
1. What is the Dystonia Panel Genetic Test and how does it work?
This NGS panel simultaneously sequences 50+ dystonia-associated genes, detecting single nucleotide variants, small indels, and copy number variations with high accuracy. It uses a peripheral whole blood sample or FTA card to extract DNA, then employs next-generation sequencing to identify pathogenic mutations linked to inherited dystonias. Results guide diagnosis, prognosis, and cascade family screening, delivered within 21–28 business days.
2. Who should consider this test and are there any special preparations?
Individuals with early-onset dystonia (onset before age 40), a family history of movement disorders, atypical or complex dystonia presentations, or those with dystonia plus other neurological features should consider testing after a comprehensive neurological evaluation. No fasting is required. A mandatory pre-test genetic counseling session is scheduled to construct a three-generation pedigree and discuss potential outcomes, including variant of uncertain significance (VUS) results. Continue all prescribed medications unless explicitly advised otherwise by your physician.
3. How will I receive my results and what support is available?
Results are delivered as a secure digital PDF report within 21–28 business days, accompanied by a complimentary telephonic clinical guidance session with our DHA-licensed consultant medical geneticist. The physician will explain the clinical significance of each finding, discuss implications for family members, and recommend appropriate follow-up steps. Insurance coverage verification is available directly via WhatsApp at +971 54 548 8731. Home sample collection is available daily from 8 AM to 11 PM through our temperature-controlled cold-chain logistics.
UAE Regulatory & Data Privacy Adherence
All genetic testing services at DNA Labs UAE comply fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the processing of sensitive health data, and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields which mandates secure electronic health information exchange. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, access-controlled, and never shared with third parties without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | Dystonia Panel Genetic Test (NGS) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 21–28 Business Days |
| Sample Type / Matrix | Whole Blood (Peripheral) or FTA Card (Dried Blood Spot) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | G24.9 |
| LOINC Code | 81314-9 |
| DHA Facility License & Lab Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians